Support of Personalized medicine Approaches in Cancer
Sector: Commercial • Location: Spain, Slovenia, Italy, Belgium, Portugal, Greece, Poland, France
Source: EU Funding & Tenders Portal
"The cancer burden in Europe, with millions of new cases and deaths annually, poses challenges for healthcare systems. Tackling this requires solutions that integrate technologies, infrastructures, and collaborative frameworks. The SPARC project focuses on addressing high-incidence cancers, such as lung and breast cancers, as well as rare cancers like neuroblastoma, by advancing diagnostics, impro
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | forthcoming |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | "The cancer burden in Europe, with millions of new cases and deaths annually, poses challenges for healthcare systems. Tackling this requires solutions that integrate technologies, infrastructures, and collaborative frameworks. The SPARC project focuses on addressing high-incidence cancers, such as lung and breast cancers, as well as rare cancers like neuroblastoma, by advancing diagnostics, improving care access, and enhancing patient outcomes. SPARC aligns with the key pillars of the forthcoming Joint Action on Personalized Medicine, ensuring a complementary approach to Member State strategies. Building on initiatives like ""Cancer Diagnostic and Treatment for All"" and ""Genomics for Public Health,"" SPARC addresses critical gaps in precision medicine. Through pilot studies (on lung, pancreatic, neuroblastoma, hematological malignancies, adrenocortical carcinoma, and melanoma cancers) the project establishes standardized protocols, harmonizes data, and fosters cross-border collaboration. SPARC emphasizes the use of advanced tools like liquid biopsy, next-generation sequencing, and AI-powered diagnostics to ensure precision care. Molecular tumor boards are integrated to enhance multidisciplinary decision-making, strengthen genomic expertise, and mitigate workforce shortages. SPARC’s transnational strategy engages 8 Member States delivering tailored solutions to reduce disparities in healthcare access and resources. By engaging healthcare professionals, patient organizations, policymakers, researchers, industry leaders, and private-sector partners, SPARC ensures a multi-stakeholder framework for advancing precision oncology. To overcome barriers to health literacy, SPARC develops multilingual resources for patients and training programs for healthcare professionals fostering trust and expertise in personalized medicine. Sustainability is a cornerstone of SPARC, with efforts to harmonize practices, integrate precision medicine into national frameworks, and ensure impact." |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
